DTL
TAK icon

Dynamic Technology Lab’s Takeda Pharmaceutical TAK Stock Holding History

Dynamic Technology Lab’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-13,944
Closed -$200K – 1523
2022
Q1 		$200K Buy
+13,944
New +$205K 0.02% 942
2021
Q1 		– Sell
-14,476
Closed -$263K – 1468
2020
Q4 		$263K Buy
+14,476
New +$254K 0.04% 722
2020
Q1 		– Sell
-14,624
Closed -$289K – 1365
2019
Q4 		$289K Buy
+14,624
New +$280K 0.05% 691

Other funds holding TAK

MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dynamic Technology Lab's TAK Position: Q2 2022 in Review

Dynamic Technology Lab sold out of Takeda Pharmaceutical (TAK) in Q2 2022, closing a stake of 13,944 shares — an estimated $200K sold.

Dynamic Technology Lab first reported a position in TAK in Q4 2019 and held it in 3 quarters. The position peaked at $289K in Q4 2019. 283 funds tracked by Wall St. Rank hold TAK as of Q2 2022.

  • Dynamic Technology Lab reported no remaining Takeda Pharmaceutical position as of Q2 2022 after selling out during the quarter.
  • Dynamic Technology Lab sold 13,944 Takeda Pharmaceutical shares in Q2 2022, an estimated $200K.
  • Dynamic Technology Lab first reported a position in Takeda Pharmaceutical in Q4 2019 and held it in 3 quarters.
  • Dynamic Technology Lab's Takeda Pharmaceutical position peaked at $289K in Q4 2019.
  • 283 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2022.

Based on Dynamic Technology Lab's 13F filing for Q2 2022, filed 12 Aug 2022.